237 related articles for article (PubMed ID: 31527683)
1. An anticancer Os(II) bathophenanthroline complex as a human breast cancer stem cell-selective, mammosphere potent agent that kills cells by necroptosis.
Novohradsky V; Markova L; Kostrhunova H; Trávníček Z; Brabec V; Kasparkova J
Sci Rep; 2019 Sep; 9(1):13327. PubMed ID: 31527683
[TBL] [Abstract][Full Text] [Related]
2. Half-sandwich Os(ii) and Ru(ii) bathophenanthroline complexes: anticancer drug candidates with unusual potency and a cellular activity profile in highly invasive triple-negative breast cancer cells.
Pracharova J; Novohradsky V; Kostrhunova H; Štarha P; Trávníček Z; Kasparkova J; Brabec V
Dalton Trans; 2018 Sep; 47(35):12197-12208. PubMed ID: 30112527
[TBL] [Abstract][Full Text] [Related]
3. Half-Sandwich Ru(II) and Os(II) Bathophenanthroline Complexes Containing a Releasable Dichloroacetato Ligand.
Štarha P; Trávníček Z; Vančo J; Dvořák Z
Molecules; 2018 Feb; 23(2):. PubMed ID: 29443934
[TBL] [Abstract][Full Text] [Related]
4. A trans-platinum(II) complex induces apoptosis in cancer stem cells of breast cancer.
Aztopal N; Karakas D; Cevatemre B; Ari F; Icsel C; Daidone MG; Ulukaya E
Bioorg Med Chem; 2017 Jan; 25(1):269-276. PubMed ID: 27839660
[TBL] [Abstract][Full Text] [Related]
5. Induction of Necroptosis in Cancer Stem Cells using a Nickel(II)-Dithiocarbamate Phenanthroline Complex.
Flamme M; Cressey PB; Lu C; Bruno PM; Eskandari A; Hemann MT; Hogarth G; Suntharalingam K
Chemistry; 2017 Jul; 23(40):9674-9682. PubMed ID: 28556445
[TBL] [Abstract][Full Text] [Related]
6. A breast cancer stem cell-selective, mammospheres-potent osmium(VI) nitrido complex.
Suntharalingam K; Lin W; Johnstone TC; Bruno PM; Zheng YR; Hemann MT; Lippard SJ
J Am Chem Soc; 2014 Oct; 136(41):14413-6. PubMed ID: 25247635
[TBL] [Abstract][Full Text] [Related]
7. Breast Cancer Stem Cell Potency of Nickel(II)-Polypyridyl Complexes Containing Non-steroidal Anti-inflammatory Drugs.
Feld CJ; Johnson A; Xiao Z; Suntharalingam K
Chemistry; 2020 Nov; 26(61):14011-14017. PubMed ID: 32485001
[TBL] [Abstract][Full Text] [Related]
8. A Triangular Platinum(II) Multinuclear Complex with Cytotoxicity Towards Breast Cancer Stem Cells.
Eskandari A; Kundu A; Ghosh S; Suntharalingam K
Angew Chem Int Ed Engl; 2019 Aug; 58(35):12059-12064. PubMed ID: 31209956
[TBL] [Abstract][Full Text] [Related]
9. A2B adenosine receptor agonist induces cell cycle arrest and apoptosis in breast cancer stem cells via ERK1/2 phosphorylation.
Jafari SM; Joshaghani HR; Panjehpour M; Aghaei M
Cell Oncol (Dordr); 2018 Feb; 41(1):61-72. PubMed ID: 29218545
[TBL] [Abstract][Full Text] [Related]
10. The Bulk Osteosarcoma and Osteosarcoma Stem Cell Activity of a Necroptosis-Inducing Nickel(II)-Phenanthroline Complex.
Eskandari A; Flamme M; Xiao Z; Suntharalingam K
Chembiochem; 2020 Oct; 21(19):2854-2860. PubMed ID: 32415808
[TBL] [Abstract][Full Text] [Related]
11. A Copper(II) Phenanthroline Metallopeptide That Targets and Disrupts Mitochondrial Function in Breast Cancer Stem Cells.
Laws K; Bineva-Todd G; Eskandari A; Lu C; O'Reilly N; Suntharalingam K
Angew Chem Int Ed Engl; 2018 Jan; 57(1):287-291. PubMed ID: 29144008
[TBL] [Abstract][Full Text] [Related]
12. Valproic acid, a histone deacetylase inhibitor, induces apoptosis in breast cancer stem cells.
Aztopal N; Erkisa M; Erturk E; Ulukaya E; Tokullugil AH; Ari F
Chem Biol Interact; 2018 Jan; 280():51-58. PubMed ID: 29225137
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting epidermal growth factor receptor signalling potentiates mesenchymal-epithelial transition of breast cancer stem cells and their responsiveness to anticancer drugs.
Manupati K; Dhoke NR; Debnath T; Yeeravalli R; Guguloth K; Saeidpour S; De UC; Debnath S; Das A
FEBS J; 2017 Jun; 284(12):1830-1854. PubMed ID: 28398698
[TBL] [Abstract][Full Text] [Related]
14. The breast cancer stem cell potency of copper(ii) complexes bearing nonsteroidal anti-inflammatory drugs and their encapsulation using polymeric nanoparticles.
Eskandari A; Boodram JN; Cressey PB; Lu C; Bruno PM; Hemann MT; Suntharalingam K
Dalton Trans; 2016 Nov; 45(44):17867-17873. PubMed ID: 27774561
[TBL] [Abstract][Full Text] [Related]
15. A tri-metallic palladium complex with breast cancer stem cell potency.
Eskandari A; Kundu A; Johnson A; Karmakar S; Ghosh S; Suntharalingam K
Dalton Trans; 2020 Apr; 49(14):4211-4215. PubMed ID: 32186576
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase (HDAC) inhibitors and doxorubicin combinations target both breast cancer stem cells and non-stem breast cancer cells simultaneously.
Hii LW; Chung FF; Soo JS; Tan BS; Mai CW; Leong CO
Breast Cancer Res Treat; 2020 Feb; 179(3):615-629. PubMed ID: 31784862
[TBL] [Abstract][Full Text] [Related]
17. CD44hiCD24lo mammosphere-forming cells from primary breast cancer display resistance to multiple chemotherapeutic drugs.
Ji P; Zhang Y; Wang SJ; Ge HL; Zhao GP; Xu YC; Wang Y
Oncol Rep; 2016 Jun; 35(6):3293-302. PubMed ID: 27109463
[TBL] [Abstract][Full Text] [Related]
18. Modulating the Chemical and Biological Properties of Cancer Stem Cell-Potent Copper(II)-Nonsteroidal Anti-Inflammatory Drug Complexes.
Shin J; Eskandari A; Suntharalingam K
Molecules; 2019 Apr; 24(9):. PubMed ID: 31035718
[TBL] [Abstract][Full Text] [Related]
19. Immunogenic Cell Death of Breast Cancer Stem Cells Induced by an Endoplasmic Reticulum-Targeting Copper(II) Complex.
Kaur P; Johnson A; Northcote-Smith J; Lu C; Suntharalingam K
Chembiochem; 2020 Dec; 21(24):3618-3624. PubMed ID: 32776422
[TBL] [Abstract][Full Text] [Related]
20. The Bulk Breast Cancer Cell and Breast Cancer Stem Cell Activity of Binuclear Copper(II)-Phenanthroline Complexes.
Osei PB; Northcote-Smith J; Fang J; Singh K; Ortu F; Suntharalingam K
Chemistry; 2023 Aug; 29(45):e202301188. PubMed ID: 37249243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
